The Foundational Role and Practical Implementation of Sensor-Based Glucose Monitoring to Optimize Clinical Outcomes in Persons with Type 2 Diabetes
Using international authorities on diabetes management, this activity will focus on emerging digital, real time-, and patch-based technologies for continuous monitoring of glucose levels, to improve drug interventions for diabetes, minimize risks of hypoglycemia, maximize time in target range for blood glucose, and to optimize treatment interventions and drug titration
MD
Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology Tulane University Health Sciences Center
New Orleans, LA
DO
Executive Director and Co-Founder Diabetes Nation High Lakes Health Care St. Charles Hospital Bend, OR
MD
Consulting Associate, Departments of Medicine Duke University Medical Center Durham, NC Inaugural Chair, ADA Primary Care Interest Group Medical Director for Performance Improvement Charlotte Area Health Education Center Charlotte, N
MD
Executive Director
International Diabetes Center- Park Nicollet
Minneapolis, MN
Establishing a “Best Practice, Best Outcomes” Standard of Care for Persons with Diabetes
Implications for Interpretation of Ambulatory Glucose Profiles (AGPs) and Time in Range Across the Full Spectrum of Persons with Diabetes
Focus on Refining and Simplifying Clinical Decision-Making Based on CGM
Barriers, Solutions, and Patient Identification
A “Best Practice/Best Outcome” Roadmap for Type 2 Diabetes—CGM for Which Patients? At What Point in their Clinical Course? For How Long? With What Goals?